Chiltern Wins PharmaTimes Awards

LONDON and WILMINGTON, North Carolina, Jan. 31, 2014 /PRNewswire/ -- Chiltern International Limited (Chiltern), a global contract research organization (CRO), announced that Chiltern has won two awards at the PharmaTimes Annual Awards 2014 ceremony that took place in London on January 30, 2014. The competition, established in 1999, celebrates the competence and ability of top clinical research professionals.

Ian Fraser, Sr. Executive Director, Clinical Operations, Western Europe, Chiltern, stated, "Chiltern's people make the difference and we are well-represented by our award winners. They are committed to giving our clients their best every day and I couldn't be more pleased for them."

Aize Smink, Chief Operating Officer, Chiltern, congratulates Chiltern's award winners Lara EdmondsonandLee-Anne Duddy. "The recognition of their outstanding abilities is well-deserved and I am extremely proud of them. Their achievements reflect Chiltern's mission to deliver innovative, flexible and quality services to meet our clients' clinical research needs."

Chiltern Award Winners
Clinical Trial Administrator of the Year Gold Award: Lara Edmondson, Trainee Clinical Research Associate

Clinical Research Associate of the Year Bronze Award: Lee-Anne Duddy, Clinical Research Associate 2

Company profile
About Chiltern:

Established in 1982, Chiltern is a leading global clinical CRO with extensive experience in the management of Phase I-IV clinical trials across a broad range of therapeutic areas, functional service provision and contract staffing solutions. Chiltern has conducted trials in more than 40 countries, employs more than 1,600 people globally and offers services in Early Phase, Global Clinical Development, Late Phase, Biometrics, Medical and Regulatory Affairs and Resourcing Solutions. Chiltern prides itself as a development partner that offers flexibility, responsiveness and quality delivery. Further information is available at: www.chiltern.com.